Adar Poonawalla
Pune • 46 years
Investments
Investment
time of Investment
About Adar Poonawalla
Adar Poonawalla is the chief executive officer (CEO) of Serum Institute of India.Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.In 2011, he became the CEO. In 2012, he played a major role in the acquisition of Bilthoven Biologicals, a Netherlands-based government vaccine manufacturing company.[6][7] Poonawalla is a board member of the GAVI Alliance, the global vaccine alliance.
Adar Poonawalla Prominent Investment Areas
Agritech and Farming Biotech Commerce and Shopping +6 more investmentsAdar Poonawalla Invested Companies
+1 more company
Key Focus Areas of invested Startups by Adar Poonawalla
AR-based Entertainment Solutions Agricultural Genomics Digital Media Platforms +10 more focus areasAdar Poonawalla Recent Experience
Chief Executive Officer
Serum Institute of India Pvt. Ltd., IndiaAcquisition
Bilthoven Biologicals, Netherlands
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly reach out to sales@ynos.in
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
